Safety and Efficacy of Permacol Injection in the Treatment of Fecal Incontinence

다국어 초록 (Multilingual Abstract)

Purpose: Permacol has been gaining popularity in recent times for the treatment of fecal incontinence (FI). This study aims to evaluate the safety and efficacy of anal submucosal Permacol injection in the treatment of FI.
Methods: All consecutive patients who underwent Permacol injection for FI over a 3-year period were included. Patients’ data relating to obstetric history, anorectal/pelvic operations, type of FI, preoperative anorectal physiology results and follow-up details for outcome measures were collected. Preoperative and postoperative Cleveland Clinic Florida Incontinence Scores (CCFISs) were noted. Patients were surveyed by using a telephone questionnaire to assess the quality of life and other outcome measures. Data were analysed using SPSS ver.19.0.
Results: Thirty patients (28 females and 2 males) with a median age of 67 years were included in the study. Of those patients, 37%, 50%, and 13% were noted to have passive, mixed and urge FI, respectively. Six of the patients (20%) had repeat Permacol injections, 5 of whom had sustained responses to the first Permacol injection for a mean of 11 months. There was a significant improvement in the CCFIS from a baseline median of 12.5, mean 12.8 (interquartile range [IQR], 6–20), to a median of 3.5, mean 4.8 (IQR, 0–20), P < 0.001. Of the patients surveyed by telephone 89% were satisfied with their overall experience and the improvement in their symptoms following Permacol injections.
Conclusion: This study has demonstrated that Permacol injection for the treatment of FI is safe and effective and has no associated major complications. However, the results are not permanent; consequently, a significant proportion of the patients with an initial response may require repeat injections.

참고문헌 (Reference)

1 University Hospital of North Norway, "Treatment of fecal Incontinence after obstetric anal sphincter injuries (KISS)" U.S. National Institutes of Health

2 Hussain ZI, "The use of Permacol injections for the treatment of fecal incontinence" 64 : 289-295, 2012

3 Hussain ZI, "Systematic review of perianal implants in the treatment of fecal incontinence" 98 : 1526-1536, 2011

4 Morgan R, "Surgical management of anorectal incontinence due to internal anal sphincter deficiency" 84 : 226-230, 1997

5 Smart N, "Submucosal injections with Permacol injection injection for fecal incontinence" 7 (7): 59-, 2005

6 Vaizey CJ, "Primary degeneration of the internal anal sphincter as a cause of passive fecal incontinence" 349 : 612-615, 1997

7 Perry S, "Prevalence of fecal incontinence in adults aged 40years or more living in the community" 50 : 480-484, 2002

8 Tjandra JJ, "Practice parameters for the treatment of fecal incontinence" 50 : 1497-1507, 2007

9 Shafik A, "Polytetrafluoroethylene injection for the treatment of partial fecal incontinence" 78 : 159-161, 1993

10 Maeda Y, "Pilot study of two new injectable bulking agents for the treatment of fecal incontinence" 10 : 268-272, 2008

11 Maeda Y, "Perianal injectable bulking agents as treatment for fecal incontinence in adults" 5 : CD007959-, 2010

12 Maslekar S, "Injectable collagen for the treatment of fecal incontinence: long-term results" 56 : 354-359, 2013

13 Vaizey CJ, "Injectable bulking agents for treating fecal incontinence" 92 : 521-527, 2005

14 National Institute for Health and Clinical Excellence, "Fecal incontinence in adults: management" NICE

15 Bharucha AE, "Fecal incontinence diagnosis and treatment" Springer 3-12, 2007

16 Tan JJ, "Evolving therapy for fecal incontinence" 50 : 1950-1967, 2007

17 Nelson R, "Community-based prevalence of anal incontinence" 274 : 559-561, 1995

18 Matzel KE, "Coloproctology" Springer 109-120, 2010

19 Santoro GA, "Benign anorectal diseases. diagnosis with endoanal and endorectal ultrasound and new treatment options" Springer 2006

20 Chattopadhyay D, "Anal bulking with Permacol injection injection to treat passive fecal incontinence: medium term results" 11 (11): 15-45, 2009